ACA Pharma Named Exclusive Distributor for Ferabright™ in Macau, Hong Kong, Singapore, Greater Bay Area & Mainland China

ACA Pharma: [email protected] Azurity Pharmaceuticals: [email protected] ...

Hyperfine Announces Enrollment of First Patient in Study to Expand Intended Use of the Swoop® System with Contrast Agents

Prospective study is designed to evaluate the feasibility and visualization benefits of contrast-enhanced ultra-low-field portable MRI.
Hosted on MSN

Bracco Imaging and Subtle Medical obtain CE mark for AI-powered MRI software

Italy-based Bracco Imaging and Subtle Medical have obtained an EU CE mark for AiMIFY, a jointly developed software designed to enhance the imaging of contrast MRI brain scans using artificial ...

Predicting microbubble distribution for blood-brain barrier opening

A clinical study shows that preoperative dynamic susceptibility contrast (DSC) perfusion magnetic resonance imaging (MRI) can ...
Business Wire

Bayer’s investigational MRI contrast agent gadoquatrane meets primary and main secondary endpoints in pivotal Phase III studies

BERLIN--(BUSINESS WIRE)--Bayer, a global leader in radiology, today announced positive topline results of the pivotal Phase III QUANTI studies evaluating the efficacy and safety of gadoquatrane, an ...
News Medical

Preclinical MRI of neurological diseases with functional and metabolic imaging

Envisioning pathological processes in the central nervous system using preclinical MRI Magnetic resonance imaging (MRI) is a well-known means of imaging for clinically managing patients with ...

Hyperfine Announces Enrollment of First Patient in Study to Expand Intended Use of the Swoop(R) System with Contrast Agents

(Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain--the Swoop (R) system--today ...